Krebs Biochemicals & Industries Ltd
₹59.67
(-0.55%)
Fri, 01 May 2026, 03:56 pm
Krebs Biochemicals & Industries Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 72.74 | 72.74 | 72.74 | 72.74 | 72.74 |
| FII | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 26.77 | 26.77 | 26.77 | 26.77 | 26.77 |
| Government | 0 | 0 | 0 | 0 | 0 |
Krebs Biochemicals & Industries Ltd Shareholding Pattern
The Krebs Biochemicals & Industries Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Krebs Biochemicals & Industries Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Krebs Biochemicals & Industries Ltd (NSE: KREBSBIO, BSE: 524518) operates in the sector and industry. Monitoring the Krebs Biochemicals & Industries Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Krebs Biochemicals & Industries Ltd Shareholding Pattern (Latest)
The latest Krebs Biochemicals & Industries Ltd shareholding for Mar 2026 is:
- Promoters: 72.74%
- FII: 0.49%
- DII: 0%
- Public: 26.77%
- Government: 0%
Promoter holding in Krebs Biochemicals & Industries Ltd remains stable, reflecting consistent long-term commitment.
Krebs Biochemicals & Industries Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Krebs Biochemicals & Industries Ltd.
- Mar 2026: 72.74%
- Dec 2025: 72.74%
- Sept 2025: 72.74%
- Jun 2025: 72.74%
- Mar 2025: 72.74%
Promoter stake remains largely stable, showing consistent ownership structure.
Krebs Biochemicals & Industries Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Krebs Biochemicals & Industries Ltd.
- Mar 2026: 0.49%
- Dec 2025: 0.49%
- Sept 2025: 0.49%
- Jun 2025: 0.49%
- Mar 2025: 0.49%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Krebs Biochemicals & Industries Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
DII holdings remain stable, reflecting steady institutional participation.
Krebs Biochemicals & Industries Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 26.77%
- Dec 2025: 26.77%
- Sept 2025: 26.77%
- Jun 2025: 26.77%
- Mar 2025: 26.77%
Public holding remains stable with consistent retail participation.
Krebs Biochemicals & Industries Ltd Government Holding
Government holding in Krebs Biochemicals & Industries Ltd currently stands at 0%.
Krebs Biochemicals & Industries Ltd operates without significant government ownership.
Krebs Biochemicals & Industries Ltd Shareholding Analysis Summary
The Krebs Biochemicals & Industries Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Krebs Biochemicals & Industries Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Krebs Biochemicals & Industries Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800